Search results

  1. 1.
    0557905 - ÚMG 2023 RIV US eng J - Journal Article
    Klánová, M. - Kazantsev, D. - Pokorná, E. - Zikmund, T. - Karolová, J. - Behounek, M. - Renesova, N. - Sovilj, D. - Kelemen, C. - Helman, K. - Jaksa, R. - Havránek, O. - Anděra, Ladislav - Trněný, M. - Klener, P.
    Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.
    Molecular Cancer Therapeutics. Roč. 21, č. 1 (2022), s. 89-99. ISSN 1535-7163. E-ISSN 1538-8514
    Institutional support: RVO:68378050
    Keywords : gene-expression * elderly-patients * bcl-2 family * venetoclax * chemotherapy * inhibition * mutations * subgroups * abt-199 * dlbcl
    OECD category: Oncology
    Impact factor: 5.7, year: 2022
    Method of publishing: Open access
    https://aacrjournals.org/mct/article/21/1/89/675161/Anti-apoptotic-MCL1-Protein-Represents-Critical
    Permanent Link: http://hdl.handle.net/11104/0331789
     
     
  2. 2.
    0554915 - ÚMG 2022 RIV CH eng J - Journal Article
    Klener, P. - Sovilj, D. - Renesova, N. - Anděra, Ladislav
    BH3 Mimetics in Hematologic Malignancies.
    International Journal of Molecular Sciences. Roč. 22, č. 18 (2021), č. článku 10157. E-ISSN 1422-0067
    Institutional support: RVO:68378050
    Keywords : apoptosis * BH3 mimetics * venetoclax * hematologic malignancies * targeted therapy * resistance * biomarkers
    OECD category: Biochemistry and molecular biology
    Impact factor: 6.208, year: 2021
    Method of publishing: Open access
    https://www.mdpi.com/1422-0067/22/18/10157
    Permanent Link: http://hdl.handle.net/11104/0329534
     
     
  3. 3.
    0554659 - BTÚ 2023 RIV US eng J - Journal Article
    Klánová, M. - Kazantsev, D. - Pokorná, E. - Zikmund, T. - Karolová, J. - Behounek, M. - Renesova, N. - Sovilj, Dana - Kelemen, Cristina D. - Helman, K. - Jaksa, R. - Havranek, O. - Anděra, Ladislav - Trněný, M. - Klener, P.
    Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.
    Molecular Cancer Therapeutics. Roč. 21, č. 1 (2022), s. 89-99. ISSN 1535-7163. E-ISSN 1538-8514
    R&D Projects: GA ČR(CZ) GA19-08772S; GA MZd(CZ) NU21-03-00386
    Institutional support: RVO:86652036
    Keywords : gene-expression * elderly-patients * bcl-2 family * venetoclax * chemotherapy
    OECD category: Oncology
    Impact factor: 5.7, year: 2022
    Method of publishing: Open access
    https://aacrjournals.org/mct/article/21/1/89/675161/Anti-apoptotic-MCL1-Protein-Represents-Critical
    Permanent Link: http://hdl.handle.net/11104/0331895
     
     
  4. 4.
    0552542 - ÚMCH 2023 RIV CH eng J - Journal Article
    Etrych, Tomáš - Braunová, Alena - Zogala, D. - Lambert, L. - Renesova, N. - Klener, P.
    Targeted drug delivery and theranostic strategies in malignant lymphomas.
    Cancers (Basel). Roč. 14, č. 3 (2022), č. článku 626. E-ISSN 2072-6694
    R&D Projects: GA ČR(CZ) GA19-01417S
    Institutional support: RVO:61389013
    Keywords : targeted drug delivery * theranostics * lymphoma
    OECD category: Polymer science
    Impact factor: 5.2, year: 2022
    Method of publishing: Open access
    https://www.mdpi.com/2072-6694/14/3/626
    Permanent Link: http://hdl.handle.net/11104/0327964
     
     
  5. 5.
    0550596 - BTÚ 2022 RIV CH eng J - Journal Article
    Klener, P. - Sovilj, Dana - Renesova, N. - Anděra, Ladislav
    BH3 Mimetics in Hematologic Malignancies.
    International Journal of Molecular Sciences. Roč. 22, č. 18 (2021), č. článku 10157. E-ISSN 1422-0067
    R&D Projects: GA MZd(CZ) NU21-03-00386; GA ČR(CZ) GA19-08772S
    Institutional support: RVO:86652036
    Keywords : apoptosis * venetoclax * BH3 mimetics * hematologic malignancies
    OECD category: Biochemistry and molecular biology
    Impact factor: 6.208, year: 2021
    Method of publishing: Open access
    https://www.mdpi.com/1422-0067/22/18/10157
    Permanent Link: http://hdl.handle.net/11104/0326720
     
     


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.